MPSF_CHICK
ID MPSF_CHICK Reviewed; 1450 AA.
AC Q02173;
DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-1994, sequence version 1.
DT 03-AUG-2022, entry version 116.
DE RecName: Full=M-protein, striated muscle;
OS Gallus gallus (Chicken).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC Phasianinae; Gallus.
OX NCBI_TaxID=9031;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Embryonic pectoralis muscle;
RX PubMed=1400348; DOI=10.1016/s0021-9258(19)88702-1;
RA Noguchi J., Yanagisawa M., Imamura M., Kasuya Y., Sakurai T., Tanaka T.,
RA Masaki T.;
RT "Complete primary structure and tissue expression of chicken pectoralis M-
RT protein.";
RL J. Biol. Chem. 267:20302-20310(1992).
CC -!- FUNCTION: Is a structural constituent of myofibrillar M-band in
CC striated muscle.
CC -!- TISSUE SPECIFICITY: Expressed in pectoralis and cardiac muscle.
CC -!- DEVELOPMENTAL STAGE: Can be detected by day 10-13 in ovo, the content
CC is gradually increased throughout the ovo development and reached its
CC peak after hatching.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D11474; BAA02033.1; -; mRNA.
DR PIR; A44027; A44027.
DR RefSeq; NP_990466.1; NM_205135.1.
DR AlphaFoldDB; Q02173; -.
DR SMR; Q02173; -.
DR STRING; 9031.ENSGALP00000026310; -.
DR PaxDb; Q02173; -.
DR PRIDE; Q02173; -.
DR GeneID; 396034; -.
DR KEGG; gga:396034; -.
DR CTD; 9172; -.
DR VEuPathDB; HostDB:geneid_396034; -.
DR eggNOG; ENOG502QS6D; Eukaryota.
DR OrthoDB; 57219at2759; -.
DR PhylomeDB; Q02173; -.
DR PRO; PR:Q02173; -.
DR Proteomes; UP000000539; Unplaced.
DR GO; GO:0031430; C:M band; IBA:GO_Central.
DR GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR CDD; cd00063; FN3; 5.
DR Gene3D; 2.60.40.10; -; 12.
DR InterPro; IPR003961; FN3_dom.
DR InterPro; IPR036116; FN3_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013098; Ig_I-set.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR Pfam; PF00041; fn3; 5.
DR Pfam; PF07679; I-set; 3.
DR SMART; SM00060; FN3; 5.
DR SMART; SM00409; IG; 5.
DR SMART; SM00408; IGc2; 4.
DR SUPFAM; SSF48726; SSF48726; 7.
DR SUPFAM; SSF49265; SSF49265; 3.
DR PROSITE; PS50853; FN3; 5.
DR PROSITE; PS50835; IG_LIKE; 4.
PE 2: Evidence at transcript level;
KW Immunoglobulin domain; Muscle protein; Reference proteome; Repeat.
FT CHAIN 1..1450
FT /note="M-protein, striated muscle"
FT /id="PRO_0000072683"
FT DOMAIN 142..233
FT /note="Ig-like C2-type 1"
FT DOMAIN 254..359
FT /note="Ig-like C2-type 2"
FT DOMAIN 373..468
FT /note="Fibronectin type-III 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 501..596
FT /note="Fibronectin type-III 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 602..695
FT /note="Fibronectin type-III 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 698..800
FT /note="Fibronectin type-III 4"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 803..900
FT /note="Fibronectin type-III 5"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 899..995
FT /note="Ig-like C2-type 3"
FT DOMAIN 1002..1115
FT /note="Ig-like C2-type 4"
FT DOMAIN 1118..1204
FT /note="Ig-like C2-type 5"
FT DOMAIN 1225..1322
FT /note="Ig-like C2-type 6"
FT DOMAIN 1333..1422
FT /note="Ig-like C2-type 7"
FT REGION 66..87
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1450 AA; 163401 MW; E313C7D39FE6CAC7 CRC64;
MSSVAVPFYQ RRHKHFDQSY RNIQTRYVLE EYAARKAASR QAAHYESTGL GKTTCRLCAR
RARSLAHEAM QESRKRTHEQ KSHASDEKRI KFASELSSLE REIHMARHHA REQLDRLAIQ
RMVEENMALE RHVVEEKISR APEILVRLRS HTVWEKMSVR LCFTVQGFPS PVVQWYKNEE
LITPASDPAK YSVENKYGVH VLHINRADFD DSATYSAVAT NIHGQASTNC AVVVRRFRES
EEPHPAGIMP FHLPLSYDVC FTHFDVQFLE KFGVTFATEG ETLTLKCSVL VTPELKRLRP
RAEWYRDDVL IKDSKWTKLY FGEGQAALSF THLNKDDEGL YTLRMVTKGG VNECSAFLFV
RDADALIAGA PGAPMDVKCH DANRDYVIVT WKPPNTTSQN PVIGYFVDKC EVGLENWVQC
NDAPVKICKY PVTGLYEGRS YIFRVRAVNS AGISRPSRVS EPVAALDPVD LERTQTVHVD
EGRKIVISKD DLEGDIQIPG PPTNVHASEI SKTYVVLSWD PPVPRGREPL TYFIEKSMVG
SGSWQRVNAQ VAVKSPRYAV FDLAEGKPYV FRVLSANKHG ISDPSEITEP IQPQDIVVVP
SAPGRVVATR NTKTSVVVQW DKPKHEENLY GYYIDYSVVG SNQWEPANHK PINYNRFVVH
GLETGEQYIF RVKAVNAVGF SENSQESEAI KVQAALTCPS YPHGITLLNC DGHSMTLGWK
APKYSGGSPI LGYYIDKREA NHKNWHEVNS SVISRTIYTV EDLTEDAFYE FKIAAANVVG
IGHPSDPSEH FKCKAWTMPE PGPAYDLTVC EVRNTSLVLL WKAPVYEGKS PITGYLVDYK
EVDTEDWITA NEKPTSHRYF KVTDLHQGHT YVFKVRAVND AGVGKSSEIS EPVFVEASPG
TKEIFSGVDE EGNIYLGFEC KEATDASHFL WGKSYEEIED SDKFKIETKG DHSKLYFKHP
DKSDLGTYCI SVSDTDGVSS SFVLDEEELE RLMTLSNEIK NPTIPLKSEL AYEVLDKGEV
RFWIQAESLS PNSTYRFVIN DKEVENGDRH KISCDHSNGI IEMVMDKFTI DNEGTYTVQI
QDGKAKNQSS LVLIGDAFKA ILAESELQRK EFLRKQGPHF SEFLYWEVTE ECEVLLACKI
ANTKKETVFK WYRNGSGIDV DEAPDLQKGE CHLTVPKLSR KDEGVYKATL SDDRGHDVST
LELSGKVYND IILALSRVSG KTASPLKILC TEEGIRLQCF LKYYNEEMKV TWSHRESKIS
SGEKMKIGGG EDVAWLQITE PTEKDKGNYT FEIFSDKESF KRTLDLSGQA FDDALTEFQR
LKAAAFAEKN RGKVIGGLPD VVTIMDGKTL NLTCTVFGNP DPEVVWFKND KALELNEHYL
VSLEQGKYAS LTIKGVTSED SGKYSIYVKN KYGGETVDVT VSVYRHGEKI PEVNQGQLAK
PRLIPPSSST
